General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements Of Changes In Stockholders' Equity

v3.19.1
Consolidated Statements Of Changes In Stockholders' Equity - USD ($)
Preferred Stock
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Income / Loss
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2016 3,275,742 8,731,029          
Beginning balance, value at Dec. 31, 2016 $ 3,275 $ 8,730 $ 163,522,921 $ (142,338,005) $ 253,734 $ (5,281,180) $ 16,169,475
Conversion of notes, shares issued   125,397          
Conversion of notes, value   $ 125 (125)        
Conversion of Series B preferred stock to shares of common stock, Shares (185,000) 185,000          
Conversion of Series B preferred stock to shares of common stock, Value $ (185) $ 185          
Share-based expense     1,784,129       1,784,129
Common stock awards to vendors     69,303       69,303
Warrant expense     (126,316)       (126,316)
Net loss       (3,595,132)     (3,595,132)
Ending balance, shares at Dec. 31, 2017 3,030,742 9,041,426          
Ending balance, value at Dec. 31, 2017 $ 3,090 $ 9,040 165,249,912 (145,933,137) 253,734 (5,281,180) 14,301,459
Accretion of deemed dividend related to Series B Preferred Stock down round provision             0
Share-based expense     383,850       383,850
Common stock awards to vendors     17,427       17,427
Warrant expense     4,917       4,917
Net loss       (1,822,518)     (1,822,518)
Ending balance, shares at Mar. 31, 2018 3,090,742 9,041,426          
Ending balance, value at Mar. 31, 2018 $ 3,090 $ 9,040 165,656,106 (147,755,655) 253,734 (5,281,180) 12,885,135
Beginning balance, shares at Dec. 31, 2017 3,030,742 9,041,426          
Beginning balance, value at Dec. 31, 2017 $ 3,090 $ 9,040 165,249,912 (145,933,137) 253,734 (5,281,180) 14,301,459
Exercise of warrants, shares   370,000          
Exercise of warrants, value   $ 370 1,479,630       1,480,000
Conversion of Series B preferred stock to shares of common stock, Shares (316,348) 316,348          
Conversion of Series B preferred stock to shares of common stock, Value $ (316) $ 316          
Share-based expense     1,351,873       1,351,873
Common stock awards to vendors     69,708       69,708
Warrant expense     10,206       10,206
Net loss       (7,300,458)     (7,300,458)
Ending balance, shares at Dec. 31, 2018 2,774,394 9,727,774          
Ending balance, value at Dec. 31, 2018 $ 2,774 $ 9,726 168,161,329 (153,233,595) (253,734) (5,281,180) 9,912,788
Issuance of common stock and warrants in March 2019 registered direct offering, net of issuance costs, value   $ 1,040,000          
Deemed dividend related to Series B Preferred Stock down round provision     3,879,447       3,879,447
Accretion of deemed dividend related to Series B Preferred Stock down round provision     $ (3,879,447)       $ (3,879,447)
Exercise of warrants, shares   1,040 2,698,010       2,699,050
Share-based expense     $ 243,089       $ 243,089
Common stock awards to vendors     17,427       17,427
Warrant expense     (26,476)       (26,576)
Net loss       (1,327,250)     (1,327,250)
Ending balance, shares at Mar. 31, 2019 2,774,394 10,767,774          
Ending balance, value at Mar. 31, 2019 $ 2,774 $ 10,766 $ 171,093,279 $ (154,560,845) $ 253,734 $ (5,281,180) $ 11,518,528